134 related articles for article (PubMed ID: 36301615)
21. Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study.
van Oirschot P; Heerings M; Wendrich K; den Teuling B; Martens MB; Jongen PJ
JMIR Mhealth Uhealth; 2020 Oct; 8(10):e18160. PubMed ID: 33016886
[TBL] [Abstract][Full Text] [Related]
22. Minimal Clinically Important Difference of Executive Function Performance in Older Adults Who Fall: A Secondary Analysis of a Randomized Controlled Trial.
Jehu DA; Davis JC; Madden K; Parmar N; Liu-Ambrose T
Gerontology; 2022; 68(7):771-779. PubMed ID: 34657043
[TBL] [Abstract][Full Text] [Related]
23. A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
Mahableshwarkar AR; Zajecka J; Jacobson W; Chen Y; Keefe RS
Neuropsychopharmacology; 2015 Jul; 40(8):2025-37. PubMed ID: 25687662
[TBL] [Abstract][Full Text] [Related]
24. Measuring Situational Cognitive Performance in the Wild: A Psychometric Evaluation of Three Brief Smartphone-Based Test Procedures.
Perzl J; Riedl EM; Thomas J
Assessment; 2023 Dec; ():10731911231213845. PubMed ID: 38097924
[TBL] [Abstract][Full Text] [Related]
25. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
Baune BT; Sluth LB; Olsen CK
J Affect Disord; 2018 Mar; 229():421-428. PubMed ID: 29331703
[TBL] [Abstract][Full Text] [Related]
26. Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J.
Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Hammer-Helmich L; Fernandez J
Neuropsychiatr Dis Treat; 2021; 17():945-955. PubMed ID: 33814911
[TBL] [Abstract][Full Text] [Related]
27. Improved cognitive function in patients with major depressive disorder after treatment with vortioxetine: A EEG study.
Kim H; Baik SY; Kim YW; Lee SH
Neuropsychopharmacol Rep; 2022 Mar; 42(1):21-31. PubMed ID: 34894110
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
McIntyre RS; Florea I; Tonnoir B; Loft H; Lam RW; Christensen MC
J Clin Psychiatry; 2017 Jan; 78(1):115-121. PubMed ID: 27780334
[TBL] [Abstract][Full Text] [Related]
29. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial.
Giosan C; Cobeanu O; Mogoaşe C; Szentagotai A; Mureşan V; Boian R
Trials; 2017 May; 18(1):215. PubMed ID: 28494802
[TBL] [Abstract][Full Text] [Related]
30. New insights into the cognitive effects of sleep deprivation by decomposition of a cognitive throughput task.
Honn KA; Halverson T; Jackson ML; Krusmark M; Chavali VP; Gunzelmann G; Van Dongen HPA
Sleep; 2020 Jul; 43(7):. PubMed ID: 32227081
[TBL] [Abstract][Full Text] [Related]
31. Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study.
Wang G; Tan KHX; Ren H; Hammer-Helmich L
Neuropsychiatr Dis Treat; 2020; 16():749-759. PubMed ID: 32214816
[TBL] [Abstract][Full Text] [Related]
32. Cognitive Impairment in Opium Use Disorder.
Sanjari Moghaddam H; Shadloo B; Shahkhah H; Tafakhori A; Haghshomar M; Meshkat S; Aghamollaii V
Behav Neurol; 2021; 2021():5548623. PubMed ID: 34373762
[TBL] [Abstract][Full Text] [Related]
33. Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study.
McCue M; Blair C; Fehnert B; King J; Cormack F; Sarkey S; Eramo A; Kabir C; Khatib R; Kemp D
JMIR Form Res; 2022 Oct; 6(10):e34923. PubMed ID: 36301599
[TBL] [Abstract][Full Text] [Related]
34. Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings.
Christensen MC; Sluth LB; McIntyre RS
J Affect Disord; 2019 Feb; 245():508-516. PubMed ID: 30439678
[TBL] [Abstract][Full Text] [Related]
35. Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder.
Murthy NV; Xu R; Zhong W; Harvey PD
J Affect Disord; 2020 Jan; 260():550-556. PubMed ID: 31539692
[TBL] [Abstract][Full Text] [Related]
36. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
Vieta E; Sluth LB; Olsen CK
J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
[TBL] [Abstract][Full Text] [Related]
37. Discriminant Validity of the WAIS-R Digit Symbol Substitution Test in Subjective Cognitive Decline, Mild Cognitive Impairment (Amnestic Subtype) and Alzheimer's Disease Dementia (ADD) in Greece.
Tsatali M; Poptsi E; Moraitou D; Agogiatou C; Bakoglidou E; Gialaouzidis M; Papasozomenou C; Soumpourou A; Tsolaki M
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34209189
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study.
Polosan M; Rabbani M; Christensen MC; Simonsen K; Ren H
Neuropsychiatr Dis Treat; 2022; 18():1963-1974. PubMed ID: 36068858
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Cognitive Impairment on the Prognosis of Major Depressive Disorder.
Zhang BH; Feng L; Feng Y; Xin LM; Zhu XY; Tan YL; Wang G
J Nerv Ment Dis; 2020 Sep; 208(9):683-688. PubMed ID: 32433202
[TBL] [Abstract][Full Text] [Related]
40. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
